Back to Newsroom
Back to Newsroom

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Denali Therapeutics Inc. (DNLI)

Friday, 14 January 2022 11:00 AM

Bronstein, Gewirtz and Grossman, LLC

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / January 14, 2022 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Denali Therapeutics Inc. ("Denali" or the "Company") (NASDAQ:DNLI). Investors who purchased Denali securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/dnli.

Bronstein, Gewirtz and Grossman, LLC, Friday, January 14, 2022, Press release picture

The investigation concerns whether Denali and certain of its officers and/or directors have violated federal securities laws.

On January 13, 2022, Denali issued a press release disclosing that on January 12, 2022, the company was informed via e-mail communication from the U.S. Food and Drug Administration (FDA) that the DNL919 (ATV:TREM2) Investigational New Drug (IND) application has been placed on clinical hold." Denali further advised that "[t]he FDA indicated they will provide an official clinical hold letter to Denali in approximately 30 days." On this news, Denali's stock price fell $4.69 per share, or 12.17%, to close at $33.86 per share on January 13, 2022.

If you are aware of any facts relating to this investigation, or purchased Denali shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/dnli. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | [email protected]

SOURCE: Bronstein, Gewirtz & Grossman, LLC

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: